← Back
$KLRS All transactions

Kalaris Therapeutics, Inc.

A

$ Value

$15.0M

Shares

1,500,000

Price

$10

Filed

Dec 22

Insider

Name

AKKARAJU SRINIVAS

Title

CIK

0001253170

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-12-22

Code

A

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,500,000

Footnotes

Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Samsara Opportunity GP and Dr. Akkaraju have voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Each of the Reporting Persons disclaims beneficial ownership in these securities except to the extent of his or its respective pecuniary interest therein. | Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001231919-25-000652

Form Type

4

Issuer CIK

0001754068

AKKARAJU SRINIVAS's History

Date Ticker Type Value
2026-02-19 MLYS A $0
2026-02-19 MLYS A $0
2026-01-09 ALMS $10.0M
2025-12-22 KLRS A $15.0M
2025-12-18 KLRS $5.0M
2025-12-12 SRRK X $7.8M
2025-12-12 SRRK X $0
2025-12-05 ALMS $581K
2025-12-05 ALMS $701K
2025-12-05 ALMS $551K

Other Insiders at KLRS (90d)

Insider Bought Sold Last
AKKARAJU SRINIVAS $5.0M 2025-12-18
Hagen Brett R
Chief Accounting Officer
$13K 2026-03-20
Feinsod Matthew
Chief Medical Officer
2026-03-19
Oxtoby Andrew
See Remarks
2026-03-19
Gall Matthew
Chief Financial Officer
2026-03-19